Neurological Biomarkers Market Is Witnessing Significant Growth Due To Rising Technological Development
Overview:
The development of biomarkers has been a key focus of research for many years. Several of these tests have helped researchers identify the most effective treatment options for specific patients. For instance, anti-CAPS antibodies have shown promising results in Parkinson’s disease and Alzheimer’s disease. Some biomarkers may also serve as potential targets for new drugs. As a result, biomarkers for neurological disorders will become a vital tool for personalized medicine. Neurological disorders are disorders of the nervous system, caused by structural abnormalities in brain cells. As a result, patients may experience a variety of symptoms. A powerful approach to understanding these diseases is possible with the development of biomarkers.
Get FREE Sample Report with Latest Covid19 Impact Analysis @ https://www.coherentmarketinsights.com/insight/request-sample/4586
Market Dynamics:
Growing technological development providing the requirement for early diagnosis of neurological diseases is expected to augment growth of the global neurological biomarkers market during the forecast period. The developments in biomarkers make neurological disorders more treatable and the technological advancement has led to faster drug development, early diagnosis, and noninvasive testing. For instance, in January 2021, Biogen Inc. in collaboration with apple, started a new virtual study for investigating the use of iPhone and Apple Watch to monitor cognitive performance and to screen the declining cognitive health including mild cognitive impairment (MCI).
However, lack of reliability and specificity of some of the neurological biomarkers is expected to restrict growth of the global neurological biomarkers market during the forecast period.
Impact of COVID-19:
The global neurological biomarkers market witnessed a major drop during the COVID-19 pandemic. The outbreak of COVID-19 in China, caused several countries to close down their borders and suspend international travel. Stringent regulations such as national lockdown were implemented to control the spread of the virus. The growth of the market declined during the pandemic due to massively disrupted global supply chain industry. However, the launch of novel vaccines and declining cases are expected to aid in regaining the lost traction.
𝐂𝐡𝐫𝐢𝐬𝐭𝐦𝐚𝐬 𝐒𝐚𝐥𝐞 𝐈𝐬 𝐋𝐢𝐯𝐞!
𝐁𝐮𝐲 𝐍𝐨𝐰 𝐓𝐨 𝐀𝐯𝐚𝐢𝐥 𝐃𝐢𝐬𝐜𝐨𝐮𝐧𝐭 𝐅𝐫𝐨𝐦 𝟐𝟓-𝟑𝟎% 𝐭𝐢𝐥𝐥 𝟑𝟏-𝐃𝐞𝐜-𝟐𝟎𝟐𝟏
Purchase This Premium Report To Access Full Information @ https://www.coherentmarketinsights.com/insight/buy-now/4586
Key takeaways:
- The global neurological biomarkers market is expected to expand, exhibiting a CAGR of XY% over the forecast period due to increasing R&D activities to improve effectiveness of neurological biomarkers. For instance, in June 2021, a new research presented by scientists at the Society of Nuclear Medicine and Molecular Imaging 2021 Annual Meeting, showed how newly developed radiotracer can measure increasing Tau-protein responsible for onset and development of Alzheimer’s disease a year before the symptoms start appearing.
- Among regions, North America is expected to witness robust growth in the global neurological biomarkers market during the forecast period, owing to growing acceptance of biomarkers as diagnostics and increasing research funding in the region.
- Key players active in the global neurological biomarkers market are Quanterix, Abbott Laboratories, DiaGenic ASA, Thermo Fisher Scientific, Inc., Myriad Genetics, Inc., Bio-Rad Laboratories, Inc., Banyan Biomarkers, Inc., Merck & Co., Inc., and Johnson & Johnson Services, Inc.
Get PDF Brochure with Latest Insights @ https://www.coherentmarketinsights.com/insight/request-pdf/4586
Table of Contents
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Overview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Biomarker Type
- Market Snippet, By Application
- Market Snippet, By End User
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- PEST Analysis
- Industry Trends
- Pipeline Analysis
- Key Highlights
- Epidemiology
- Brand Analysis
- Regulatory Scenario
- Market Dynamics
- Global Neurological Biomarkers Market – Impact of Coronavirus (Covid-19) Pandemic
- COVID-19 Epidemiology
- Impact of COVID-19 on Demand and Supply of Neurological Biomarkers
- Impact of Covid-19 on the Neurological Biomarkers Market
- Global Neurological Biomarkers Market, By Biomarker Type, 2017-2028 (US$ Million)
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2018 – 2028
- Segment Trends
- Imaging biomarkers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Metabolomics Biomarkers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Proteomic Biomarkers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Genomics Biomarkers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Introduction
- Global Neurological Biomarkers Market, By Application, 2017 – 2028 (US$ Million)
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2018 – 2028
- Segment Trends
- Alzheimer’s Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Parkinson’s Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Multiple Sclerosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Autism Spectrum Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Introduction
- Global Neurological Biomarkers Market, By End User, 2017 – 2028 (US$ Million)
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2018 – 2028
- Segment Trends
- Hospital Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Clinical Diagnostic Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Research Organizations
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Introduction
About Us:
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact US:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837